載入...
Exosomal PD-L1: Roles in tumor progression and immunotherapy
The use of immune checkpoint therapies targeting programmed death-1 (PD-1) and its ligand (PD-L1) continue to show limited, durable success in clinical cases, despite widespread application. While some patients achieve complete responses and disease remission, others are completely resistant to the...
Na minha lista:
| 發表在: | Trends Cancer |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330176/ https://ncbi.nlm.nih.gov/pubmed/32610067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2020.03.002 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|